Myriad Genetics, a US-listed biotech, has joined the $20m series E round for RainDance Technologies, a local gene-sequencing service provider.
All of RainDance’s previous venture capital investors also participated in the round: Mohr Davidow Ventures, Quaker BioVentures, Alloy Ventures, Acadia Woods and Sectoral Asset Management.
RainDance previously raised $37.5m in its D round in January 2011, while it was raising $12m in 2009’s C round.
Bill Ericson, general partner at Mohr Davidow Ventures and a member of the RainDance board…